InspireMD, Inc.
For the period ended Jun 30, 2025. Filed Aug 4, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 4, 2025
NSPR$0.78+9.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(U.S. dollars in thousands)
| 2025 | 2024 | |
|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||
| Net loss | $(24,317) | $(14,941) |
| Adjustments required to reconcile net loss to net cash used in operating activities: | ||
| Depreciation | 205 | 135 |
| Changes in fair value of marketable securities, net of interest received | (155) | (435) |
| Change in liability for employees’ rights upon retirement | 277 | 61 |
| Other financial expenses (income) | (58) | 14 |
| Change in operating right of use asset and operating leasing liability | 377 | (55) |
| Share-based compensation expenses | 5,940 | 5,349 |
| Loss (gain) on amounts funded in respect of employee rights upon retirement, net | (95) | 34 |
| Changes in operating asset and liability items: | ||
| Decrease (increase) in prepaid expenses | 113 | (139) |
| Decrease (increase) in trade receivables | (20) | 497 |
| Decrease in other receivables | 186 | 198 |
| Increase in inventory | (484) | (100) |
| Increase (decrease) in trade payables | 264 | (12) |
| Increase (decrease) in other payables | 642 | (24) |
| Net cash used in operating activities | (17,125) | (9,418) |
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||
| Purchase of property, plant and equipment | (935) | (670) |
| Investments in marketable securities | (11,749) | (1,960) |
| Proceeds from matured marketable securities | 19,760 | 13,000 |
| Amounts funded in respect of employee rights upon retirement | (52) | (47) |
| Net cash provided by investing activities | 7,024 | 10,323 |
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||
| Proceeds from exercise of warrants | 1,947 | 17,854 |
| Proceeds from issuance of shares, net of $22 issuance costs | 696 | - |
| Net cash provided by financing activities | 2,643 | 17,854 |
| EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS | 51 | (14) |
| INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | (7,407) | 18,745 |
| BALANCE OF CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE PERIOD | 18,916 | 9,640 |
| BALANCE OF CASH AND CASH EQUIVALENTS AT END OF THE PERIOD | $11,509 | $28,385 |
| SUPPLEMENT NON-CASH INVESTING AND FINANCING ACTIVITIES: | ||
| Issuance Costs not yet paid | 109 | 1,000 |
| Acquisition of right-of-use assets by means of lease liabilities | 994 | - |
The accompanying notes are an integral part of the consolidated financial statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.